MEDIMI Stock Overview
Develops, manufactures, and markets e-health solutions in Sweden. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Medimi AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 0.006 |
| 52 Week High | SEK 0.039 |
| 52 Week Low | SEK 0.003 |
| Beta | -0.34 |
| 11 Month Change | -31.82% |
| 3 Month Change | -71.15% |
| 1 Year Change | -81.25% |
| 33 Year Change | -98.40% |
| 5 Year Change | -98.36% |
| Change since IPO | -99.85% |
Recent News & Updates
Recent updates
Shareholder Returns
| MEDIMI | SE Medical Equipment | SE Market | |
|---|---|---|---|
| 7D | 57.9% | -4.1% | -2.1% |
| 1Y | -81.3% | -9.7% | 10.8% |
Return vs Industry: MEDIMI underperformed the Swedish Medical Equipment industry which returned -9.7% over the past year.
Return vs Market: MEDIMI underperformed the Swedish Market which returned 10.8% over the past year.
Price Volatility
| MEDIMI volatility | |
|---|---|
| MEDIMI Average Weekly Movement | 33.8% |
| Medical Equipment Industry Average Movement | 7.5% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in SE Market | 11.2% |
| 10% least volatile stocks in SE Market | 3.3% |
Stable Share Price: MEDIMI's share price has been volatile over the past 3 months compared to the Swedish market.
Volatility Over Time: MEDIMI's weekly volatility has increased from 23% to 34% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 6 | Johan Wiesel | www.medimiab.com |
Medimi AB (publ) develops, manufactures, and markets e-health solutions in Sweden. It offers Medimi Smart, a comprehensive system for medicine handling; and MedimiFlex, an administration system. The company was formerly known as MedicPen AB (publ) and changed its name to Medimi AB (publ) in May 2021.
Medimi AB (publ) Fundamentals Summary
| MEDIMI fundamental statistics | |
|---|---|
| Market cap | SEK 6.47m |
| Earnings (TTM) | -SEK 13.64m |
| Revenue (TTM) | SEK 4.17m |
1.6x
P/S Ratio-0.5x
P/E RatioIs MEDIMI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MEDIMI income statement (TTM) | |
|---|---|
| Revenue | SEK 4.17m |
| Cost of Revenue | SEK 2.47m |
| Gross Profit | SEK 1.70m |
| Other Expenses | SEK 15.34m |
| Earnings | -SEK 13.64m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Nov 25, 2024
| Earnings per share (EPS) | -0.013 |
| Gross Margin | 40.75% |
| Net Profit Margin | -326.89% |
| Debt/Equity Ratio | 38.7% |
How did MEDIMI perform over the long term?
See historical performance and comparison